Renal cell carcinoma with atypical omental metastasis: A case report and literature review

Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of RCC, is known to show early metastatic potential but remains poorly understood. We present a rare case of synchronous FH‐deficient RCC with isolated omental metastasis identified at diagnosis. Case Presentation We report the case of a 48‐year‐old man who first presented with abdominal pain, early satiety, and a 25‐pound weight loss. Imaging revealed an 11.8 cm right renal mass with a separate 15.4 cm left upper quadrant mesenteric mass with no definitive evidence of lung, bone, or liver involvement. Biopsies of both renal and mesenteric masses confirmed non‐clear‐cell FH‐deficient RCC with papillary architecture and diffuse overexpression of 2‐succinyl cysteine. Conclusion Omental metastasis of RCC is rare, especially in the absence of prior surgery. This case is distinguished by its synchronous presentation of the primary RCC and omental metastasis with a rare histologic subtype. Unlike most documented reports of RCC with omental spread, which typically involve clear cell histology and often present years after nephrectomy, this case involves a rare, aggressive subtype with atypical metastatic behavior. This case underscores the importance of considering atypical metastatic patterns in non‐clear‐cell subtypes and the need for further research to inform evidence‐based therapy.

Authors

Institutions

Publication Details

Journal
UroPrecision
Published
2025-09-10
DOI
https://doi.org/10.1002/uro2.70032
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Renal cell carcinoma with atypical omental metastasis: A case report and literature review

Katherine Wu, Zhihong Guo, Aihua Jing, Wei Wang et al.
2 links
UroPrecision
Renal cell carcinoma treatment
article

Renal cell carcinoma with atypical omental metastasis: A case report and literature review

Katherine Wu, Zhihong Guo, Aihua Jing, Wei Wang, James Jing
article en

Abstract

Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of RCC, is known to show early metastatic potential but remains poorly understood. We present a rare case of synchronous FH‐deficient RCC with isolated omental metastasis identified at diagnosis. Case Presentation We report the case of a 48‐year‐old man who first presented with abdominal pain, early satiety, and a 25‐pound weight loss. Imaging revealed an 11.8 cm right renal mass with a separate 15.4 cm left upper quadrant mesenteric mass with no definitive evidence of lung, bone, or liver involvement. Biopsies of both renal and mesenteric masses confirmed non‐clear‐cell FH‐deficient RCC with papillary architecture and diffuse overexpression of 2‐succinyl cysteine. Conclusion Omental metastasis of RCC is rare, especially in the absence of prior surgery. This case is distinguished by its synchronous presentation of the primary RCC and omental metastasis with a rare histologic subtype. Unlike most documented reports of RCC with omental spread, which typically involve clear cell histology and often present years after nephrectomy, this case involves a rare, aggressive subtype with atypical metastatic behavior. This case underscores the importance of considering atypical metastatic patterns in non‐clear‐cell subtypes and the need for further research to inform evidence‐based therapy.

UroPrecisionVol. 4(1)
The University of Texas MD Anderson Cancer Center (US), McLaren Macomb (US), The University of Texas at Austin (US)
Openalex Percentile: Top 65%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.